MedPath

The impact of physical activity on breast cancer survivors

Not Applicable
Conditions
The impact of physical activity on health in breast cancer survivors
Not Applicable
Registration Number
ISRCTN45696887
Lead Sponsor
Akademii Wychowania Fizycznego im. Jerzego Kukuczki w Katowicach
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Ongoing
Sex
Female
Target Recruitment
180
Inclusion Criteria

1. Patient's written consent to participate in the study
2. Age 30 - 70 years
3. First treatment of non-disseminated breast cancer
4. 0 - III degree of cancer
5. Overweight and obesity (BMI >25 kg/m²)
4. Treatment of breast cancer (mastectomy and minimally invasive surgery)
5. Adjuvant treatment (chemotherapy, immunotherapy, hormone therapy, radiotherapy) based on the medical indications
6. Completed radiotherapy and chemotherapy from 4 weeks to 6 months before the study start
7. No physical training for more than 60 minutes a week before the start of the study
8. Hormone therapy and/or immunotherapy,
9. Minimum of 5 years from the end of treatment for another malignant tumor

Exclusion Criteria

1. Contraindications to physical training at the intensity specified in the study
2. Refusal to participate in the study
3. Co-morbidities disrupting the body’s balance including diseases of the nervous system, balance organ, eyes, muscles and joints (amputations, unequal limb length >2 cm, joint stiffness and limited range of movement in lower extremities above 15 degrees)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<br> 1. Quality of life assessed with the EORTC QLQ – C30 - Quality of Life Questionnaire of Cancer Patients at baseline, after finishing 6-week physical training and 6 weeks after treatment<br> 2. Quality of life assessed with the EORTC QLQ – BR 23 - Quality of Life Questionnaire for Breast Cancers at baseline, after finishing 6-week physical training and 6 weeks after treatment<br> 3. Postural stability assessed by AMTI's AccuGait Optimized™ multi-axis force platform tests at baseline, after finishing 6-week physical training and 6 weeks after treatment<br> 4. Postural stability assessed by Timed Up and Go test (TUG) at baseline, after finishing 6-week physical training and 6 weeks after treatment<br>
Secondary Outcome Measures
NameTimeMethod
<br> 1. Physical activity level assessed by Physical Activity Questionnaire (IPAQ) questionnaire at baseline, after finishing 6-week physical training and 6 weeks after treatment<br> 2. Fatigue level assessed by Brief Fatigue Inventory (BFI) at baseline, after finishing 6-week physical training and 6 weeks after treatment<br> 3. Locomotor function assessed by 4-Meter Gait Speed test (4MGS) at baseline, after finishing 6-week physical training and 6 weeks after treatment<br> 4. Pain is measured using a visual analogue scale (VAS) at baseline, after finishing 6-week physical training and 6 weeks after treatment<br> 5. Fall risk is measured using the Falls Efficacy Scale-International (FES-I) at baseline, after finishing 6-week physical training and 6 weeks after treatment<br>
© Copyright 2025. All Rights Reserved by MedPath